181 related articles for article (PubMed ID: 27711957)
1. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
[No Abstract] [Full Text] [Related]
2. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
[No Abstract] [Full Text] [Related]
3. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
[No Abstract] [Full Text] [Related]
5. Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.
Anagnostis P; Florou P; Bosdou JK; Grimbizis GF; Iakovou I; Kolibianakis EM; Goulis DG
Maturitas; 2021 Jun; 148():40-45. PubMed ID: 34024350
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.
Giusti M; Mittica M; Comite P; Campana C; Gay S; Mussap M
Endocrine; 2018 Jun; 60(3):516-523. PubMed ID: 29302874
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
[No Abstract] [Full Text] [Related]
8. Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.
Barreto MCA; Treistman N; Cavalcante LBCP; Bulzico D; de Andrade FA; Corbo R; Alves Junior PAG; Vaisman F
Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38290210
[TBL] [Abstract][Full Text] [Related]
9. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the serum luteinizing hormone to folliclestimulating hormone ratio and the anti-Müllerian hormone levels in normo-ovulatory women.
Lee JE; Yoon SH; Kim HO; Min EG
J Korean Med Sci; 2015 Mar; 30(3):296-300. PubMed ID: 25729253
[TBL] [Abstract][Full Text] [Related]
11. Ovarian Reserve Assessment in Celiac Patients of Reproductive Age.
Cakmak E; Karakus S; Demirpence O; Demet Coskun B
Med Sci Monit; 2018 Feb; 24():1152-1157. PubMed ID: 29476685
[TBL] [Abstract][Full Text] [Related]
12. The effects of uterine artery embolization on ovarian reserve.
Kim CW; Shim HS; Jang H; Song YG
Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():172-176. PubMed ID: 27697621
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
14. Antimullerian hormone in cases of different reproductive pathologies.
Barbakadze L; Kristasashvili J
Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
[TBL] [Abstract][Full Text] [Related]
15. Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine.
Adamska A; Tomczuk-Bobik P; Popławska-Kita AB; Siewko K; Buczyńska A; Szumowski P; Żukowski Ł; Myśliwiec J; Zbucka-Krętowska M; Adamski M; Krętowski AJ
Endocr Connect; 2021 Oct; 10(10):1283-1290. PubMed ID: 34524978
[TBL] [Abstract][Full Text] [Related]
16. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
17. Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values.
Polyzos NP; Sakkas E; Vaiarelli A; Poppe K; Camus M; Tournaye H
Hum Reprod; 2015 Jul; 30(7):1690-6. PubMed ID: 25948573
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
19. Is there any correlation between amh and obesity in premenopausal women?
Sahmay S; Usta T; Erel CT; Imamoğlu M; Küçük M; Atakul N; Seyisoğlu H
Arch Gynecol Obstet; 2012 Sep; 286(3):661-5. PubMed ID: 22552379
[TBL] [Abstract][Full Text] [Related]
20. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
